TMS INSURANCE COVERAGE STARTS TO GAIN GOUND IN THE WEST
Good news for Californians suffering from medication-resistant clinical depression: The insurance industry in California is finally starting to recognize the need to cover transcranial magnetic stimulation for depression. TMS Insurance Coverage is key to making TMS, a new, non-drug, outpatient, safe and FDA-approved treatment for depression, accessible to those who suffer from depression.
Anthem Blue Cross — one of the nation’s largest health benefits companies, with nearly 34 million members in its affiliated health plans — issued a coverage policy for Transcranial Magnetic Stimulation (TMS) Therapy for depression, effective on August 13, 2012. Anthem insurance plans operate in 14 states. It is expected that this will lead the way for TMS insurance coverage from other health insurance companies.
TMS INSURANCE COVERAGE LIKELY REFLECTS THE STRONG BENEFICIAL EFFECTS AND LOW SIDE EFFECTS OF TMS
NeuroStar TMS Therapy is indicated for the treatment of major depression in adult patients who have failed to achieve satisfactory improvement from one prior antidepressant medication at or above the minimal effective dose and duration in the current episode.
TMS INSURANCE COVERAGE LIKELY REFLECTS THE COST EFFECTIVENESS OF TMS
Ask your health insurance company if there is TMS insurance coverage for depression, and if not, ask them why. In a 2008 study supported by the National Institute of Mental Health (NIMH), TMS was found to be cost-effective even when reimbursements by insurance companies were as high as $400 per session. When increased personal productivity and reduced health care costs were factored in, TMS was proven to be even more cost effective longterm.